Skip to main content
. 2019 Mar 22;10:256. doi: 10.3389/fneur.2019.00256

Table 1.

Characteristics of controls and patients having LID.

Characteristics Mean ± SD Range
Controls (n = 69; 30 Females)
  Age (year) 68.1 ± 7.7 45–82
  MMSE (/30) 28.6 ± 1.5 23–30
  GDS-15 (/15) 1.7 ± 2.0 0–11
Patients (n = 88; 41 Females)
  Age (year) 67.5 ± 8.7 37–83
  MMSE (/30) 27.3 ± 2.5 19–30
  GDS-15 (/15) 3.7 ± 2.8 0–13
  Years since diagnosis 10.4 ± 5.5 1–30
  LEDD (mg)a 1048.9 ± 520.0 200–2,790
MDS-UPDRS PART III ONb
  Speech 1.2 ± 1.0 0–4
  Facial expression (3.2) 1.6 ± 1.0 0–4
  Arms rigidity (3.3)c 0.7 ± 0.7 0–2.5
  Legs rigidity (3.3)c 1.1 ± 0.8 0–4
  Arising from chair (3.9) 0.4 ± 0.7 0–3
  Gait (3.10) 1.1 ± 0.9 0–3
  Freezing of gait (3.11) 0.3 ± 0.7 0–4
  Postural instability (3.12) 1.2 ± 1.0 0–4
  Posture (3.13) 0.8 ± 0.9 0–3
  Bradykinesia (3.14) 1.0 ± 1.0 0–4
  Postural tremor (3.15)c 0.4 ± 0.8 0–4
  Rest tremor (3.17)c 0.2 ± 0.5 0–3
MDS-UPDRS PART IVb
  Time spent with LID (4.1) 1.6 ± 0.9 0–4
  Functional impact of LID (4.2) 1.7 ± 1.0 0–4
  Hoehn and Yahr score ONb 2.3 ± 0.7 1–4
a

Missing data for 9 participants.

b

Higher score indicates worse functioning.

c

Score represent the mean of the left and right segments.

GDS-15, 15-item Geriatric Depression Scale; MDS-UPDRS, Movement Disorder Society-Unified Parkinson's Disease Rating Scale; SD, Standard deviation, LEDD, Levodopa Equivalent Daily Dose.